CFM
PYXS icon

Cornerstone Financial Management’s Pyxis Oncology PYXS Stock Holding History

Cornerstone Financial Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518 Hold
172
– – ﹤0.01% 1365
2026
Q1 		$251 Hold
172
– – ﹤0.01% 1295
2025
Q4 		$198 Buy
+172
New +$607 ﹤0.01% 1232

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Financial Management's PYXS Position: Q2 2026 in Review

Cornerstone Financial Management held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 172 shares worth $518. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

Cornerstone Financial Management first reported a position in PYXS in Q4 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Cornerstone Financial Management held 172 shares of Pyxis Oncology worth $518 as of Q2 2026.
  • Cornerstone Financial Management left its Pyxis Oncology share count unchanged in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #1365 holding.
  • Cornerstone Financial Management first reported a position in Pyxis Oncology in Q4 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.